Table 1.
Sample type/procedure | Cross-sectional survey | Routine survey | Passive case detection | CCM | MSAT | DMFA |
Axillary temperature and clinical assessment | X | X | X | X | X | |
Dried blood spot (DBS) | X | X | X | X* | X | |
Whole blood in RNA protect | X | X | X | X* | X | X |
Whole blood for DNA | X | X | X | X* | X | X |
Rapid diagnostic test (RDT) | X* | X | X* | X | ||
Highly sensitive RDT (HS-RDT) | X | |||||
Plasma | X | |||||
Blood smear | X† | X† | X† | X |
*Sampling only takes place if the subject has fever or history of fever in the last 24 hours.
†Sampling only takes place if the subject has a history of antimalaria treatment in the previous 3 weeks for microscopic confirmation of malarial infection.
CCM, enhanced community case management; DMFA, direct membrane feeding assay; MSAT, monthly screening and treatment.